Matribhumi Samachar English
Vancouver, British Columbia–(Newsfile Corp. – June 30, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (“PreveCeutical” or the “Company”), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to have appointed Dr. Francis Tavares as a corporate advisor …
Read More »PreveCeutical Announces Non-Brokered Private Placement
Vancouver, British Columbia–(Newsfile Corp. – June 11, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), is pleased to announce a non-brokered private placement (the “Offering“) of up to 15,000,000 units in the capital of the Company (the “Units“) at a price of $0.05 per Unit …
Read More »PreveCeutical Welcomes Stephen Glover as Corporate Advisor
Vancouver, British Columbia–(Newsfile Corp. – May 26, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (“PreveCeutical” or the “Company”), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that Steve Glover has been appointed as …
Read More »PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement
Vancouver, British Columbia–(Newsfile Corp. – May 22, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), is pleased to announce that, following its news releases dated April 2, 2025, April 14, 2025, and April 28, 2025, it has successfully closed the final tranche (“Final Tranche”) of …
Read More »PreveCeutical Announces Up-Sized Non-Brokered Private Placement
Vancouver, British Columbia–(Newsfile Corp. – April 14, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”) announces that, further to its news release dated April 2, 2025, that the Company will be increasing the size of its previously announced non- brokered private placement (the …
Read More »PreveCeutical Announces Update to Non-Brokered Private Placement
Vancouver, British Columbia–(Newsfile Corp. – April 2, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), is pleased to announce a non-brokered private placement (the “Offering”) of up to 16,666,667 units in the capital of the Company (the “Units”) at a price of $0.03 …
Read More »PreveCeutical Announces Update to Private Placement
Vancouver, British Columbia–(Newsfile Corp. – March 10, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), announces that further to its news release dated January 24, 2025, the Company has received an extension from The CSE (the “CSE”) to close its non-brokered private placement …
Read More »